Advertisement
Advertisement

GOVX

GOVX logo

GeoVax Labs, Inc. New

0.75
USD
Sponsored
-0.02
-2.07%
Aug 10, 15:59 UTC -4
Closed
exchange

After-Market

0.77

+0.01
+1.72%

GeoVax Labs, Inc. New Profile

About

GeoVax Labs Inc. is a clinical-stage biotechnology company. It engages in developing human vaccines against infectious diseases and cancer using a novel patented Modified Vaccinia Ankara-Virus Like Particle based vaccine platform. GeoVax Labs Inc. is based in ATLANTA, GA.

Info & Links

CEO

David A. Dodd

Headquarters

1955 LAKE PARK DRIVE, SUITE 300
SMYRNA, GA 30080, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.geovax.com

Auditor

WIPFLI LLP

Share holders

25

Employees

19

GeoVax Labs, Inc. New Statistics

Valuation Measures

Market Capitalization2

4M

Enterprise Value

853.03K

Enterprise Value/EBITDA(ttm)

-0.04

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

0.44

Price to Book(mrq)

1.52

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-743.64%

Return on Invested Capital(ttm)

-1561.35%

Return on Assets(ttm)

-394.74%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-20.47M

Net Income Available to Common(ttm)

-20.43M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

3.73

52-Week Change

-95.56%

S&P 500 52-Week Change

21.65%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

7.37M

Dividend Yield

0.00%

Float4

3.45M

% Held by Insiders

0.69%

% Held by Institutions

6.09%

Balance Sheet

Total Cash(mrq)

3.14M

Total Cash Per Share(mrq)

0.43

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

1.54%

Quick Ratio(mrq)

1.54%

Book Value Per Share(mrq)

0.24

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.58

Free Cash Flow(ytd)

-7.20M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement